Ovarian Cancer Stage IIIC
1 competing product in clinical development for Ovarian Cancer Stage IIIC.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| CS-1008 + Paclitaxel + Carboplatin | Daiichi Sankyo | Phase 2 | Completed | 35 |
1 competing product in clinical development for Ovarian Cancer Stage IIIC.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| CS-1008 + Paclitaxel + Carboplatin | Daiichi Sankyo | Phase 2 | Completed | 35 |